24 research outputs found
DB2 COST-EFFECTIVENESS ANALYSIS OF PREGABALIN FOR THE MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY IN MEXICO
Get PDFPCV52 ECONOMIC EVALUATION OF DALTEPARIN FOR THE MANAGEMENT OF THROMBOEMBOLIC VENOUS DISEASE (VTE) AFTER TOTAL KNEE ARTHROPLASTY IN MEXICO
Get PDFCatastrophic and Impoverishing Health Expenditure in Argentina, 1997-2005
No full textĂrea de EconomĂ
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)
No full textPCN94 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in the IMSS (Mexican Institute of Social Security)
No full textPSS10 Cost- Effectiveness of Ranibizumab in Patients with Neovascular Wet Age-Related Macular Degeneration (Namd) at the Mexican Social Security System (Imss)
No full textPCV53 A PHARMACOECONOMIC ANALYSIS OF PROPHYLAXIS THERAPIES AND TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) IN MEXICAN PATIENTS WITH CANCER
No full textDB2 COST-EFFECTIVENESS ANALYSIS OF PREGABALIN FOR THE MANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY IN MEXICO
No full textPMH23 PREGABALIN FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDERS (GAD) â A COST-EFFECTIVENESS CASE STUDY OF MEXICO
No full textCE2 COST-EFFECTIVENESS OF SILDENAFIL IN THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION IN MEXICAN ADULT PATIENTS
No full text
